Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-5601, USA.
BMC Vet Res. 2012 Sep 1;8:153. doi: 10.1186/1746-6148-8-153.
Dehorning is a common practice involving calves on dairy operations in the United States. However, less than 20% of producers report using analgesics or anesthetics during dehorning. Administration of a systemic analgesic drug at the time of dehorning may be attractive to dairy producers since cornual nerve blocks require 10 - 15 min to take effect and only provide pain relief for a few hours. The primary objectives of this trial were to (1) describe the compartmental pharmacokinetics of meloxicam in calves after IV administration at 0.5 mg/kg and (2) to determine the effect of meloxicam (n = 6) or placebo (n = 6) treatment on serum cortisol response, plasma substance P (SP) concentrations, heart rate (HR), activity and weight gain in calves after scoop dehorning and thermocautery without local anesthesia.
Plasma meloxicam concentrations were detectable for 50 h post-administration and fit a 2-compartment model with a rapid distribution phase (mean T(1/2α) = 0.22 ± 0.087 h) and a slower elimination phase (mean T(1/2β) = 21.86 ± 3.03 h). Dehorning caused a significant increase in serum cortisol concentrations and HR (P < 0.05). HR was significantly lower in the meloxicam-treated calves compared with placebo-treated calves at 8 h (P = 0.039) and 10 h (P = 0.044) after dehorning. Mean plasma SP concentrations were lower in meloxicam treated calves (71.36 ± 20.84 pg/mL) compared with control calves (114.70 ± 20.84 pg/mL) (P = 0.038). Furthermore, the change in plasma SP from baseline was inversely proportional to corresponding plasma meloxicam concentrations (P = 0.008). The effect of dehorning on lying behavior was less significant in meloxicam-treated calves (p = 0.40) compared to the placebo-treated calves (P < 0.01). Calves receiving meloxicam prior to dehorning gained on average 1.05 ± 0.13 kg bodyweight/day over 10 days post-dehorning compared with 0.40 ± 0.25 kg bodyweight/day in the placebo-treated calves (p = 0.042).
To our knowledge, this is the first published report examining the effects of meloxicam without local anesthesia on SP, activity and performance of calves post-dehorning. These findings suggest that administration of meloxicam alone immediately prior to dehorning does not mitigate signs of acute distress but may have long term physiological, behavior and performance effects.
去角是美国奶牛场常见的小牛操作。然而,不到 20%的生产者报告在去角时使用镇痛药或麻醉剂。在去角时给予全身性镇痛药可能对奶牛生产者具有吸引力,因为角神经阻滞需要 10-15 分钟才能起效,并且仅能提供数小时的止痛效果。本试验的主要目的是:(1)描述 0.5mg/kg 静脉内给药后,美洛昔康在小牛中的隔室药代动力学;(2)确定美洛昔康(n=6)或安慰剂(n=6)治疗对无局部麻醉的 scooping 去角和热烙后小牛血清皮质醇反应、血浆 P 物质(SP)浓度、心率(HR)、活动和体重增加的影响。
去角后 50 小时内可检测到血浆美洛昔康浓度,并符合 2 隔室模型,具有快速分布相(平均 T(1/2α)=0.22±0.087h)和较慢的消除相(平均 T(1/2β)=21.86±3.03h)。去角导致血清皮质醇浓度和 HR 显著升高(P<0.05)。去角后 8 小时(P=0.039)和 10 小时(P=0.044),美洛昔康治疗的小牛 HR 明显低于安慰剂治疗的小牛。与对照组小牛(114.70±20.84pg/ml)相比,美洛昔康治疗的小牛的平均血浆 SP 浓度较低(71.36±20.84pg/ml)(P=0.038)。此外,从基线开始,血浆 SP 的变化与相应的血浆美洛昔康浓度呈反比(P=0.008)。与安慰剂治疗的小牛(P<0.01)相比,接受去角前给予美洛昔康的小牛(P=0.40)的卧姿行为变化不那么明显。与安慰剂治疗的小牛(P=0.042)相比,接受去角前给予美洛昔康的小牛在去角后 10 天内平均每天增加 1.05±0.13kg 体重,而安慰剂治疗的小牛每天增加 0.40±0.25kg 体重。
据我们所知,这是第一个发表的报告,研究了在没有局部麻醉的情况下,美洛昔康对去角后小牛 SP、活动和性能的影响。这些发现表明,在去角前单独给予美洛昔康并不能减轻急性疼痛的迹象,但可能对小牛的生理、行为和性能产生长期影响。